We are able to recruit even rare trial populations fast and reliably.Our database is exclusive to people actively seeking to take part in clinical trials. This is a significant improvement over most databases of patients as these contain a majority of patients who are reluctant to participate in a clinical study.
First patient enrolled in telehealth study, the Pathway Study
February 25, 2025
The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and the National Amyloidosis Centre and aims...
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
-min.jpg)
.jpg)
